Reduced Adiposity and High-Fat Diet-Induced Adipose Inflammation in Mice Deficient for Phosphodiesterase 4B
Open Access
- 9 April 2009
- journal article
- other
- Published by The Endocrine Society in Endocrinology
- Vol. 150 (7), 3076-3082
- https://doi.org/10.1210/en.2009-0108
Abstract
The concept that obesity is an inflammatory state has changed our understanding of this condition and suggested that pharmacological interventions targeting inflammation may be useful strategies to improve metabolic complications of obesity. Phosphodiesterase 4 (PDE4) inhibitors exhibit profound antiinflammatory effects, but whether PDE4 inhibition suppresses obesity-induced inflammation is unknown. Among PDE4 isoforms, PDE4B is the major species mediating inflammatory responses. We therefore examined obesity-related phenotypes in mice deficient for PDE4B. Compared with wild-type littermates, PDE4B-null mice were leaner, with lower fat pad weights, smaller adipocytes, and decreased serum leptin levels on both chow and high-fat diets (HFDs). PDE4B deficiency suppressed TNF-α mRNA levels and macrophage infiltration in white adipose tissue in mice on HFD, but insulin sensitivity was unaltered. PDE4B-null mice on HFDs had increased locomotor activity. These results suggest a previously unappreciated role for PDE4B in the regulation of energy balance and that PDE4B inhibitors could have utility in treatment of obesity and for suppression of obesity-induced inflammation in white adipose tissue.Keywords
This publication has 73 references indexed in Scilit:
- Critical Role of PDE4D in β2-Adrenoceptor-dependent cAMP Signaling in Mouse Embryonic FibroblastsOnline Journal of Public Health Informatics, 2008
- Anxiogenic-Like Behavioral Phenotype of Mice Deficient in Phosphodiesterase 4B (PDE4B)Neuropsychopharmacology, 2007
- Inflammation and metabolic disordersNature, 2006
- Inflammation and insulin resistanceJCI Insight, 2006
- Reduced PDE4 expression and activity contributes to enhanced catecholamine‐induced cAMP accumulation in adipocytes from FOXC2 transgenic miceFEBS Letters, 2006
- Effects of Etanercept in Patients With the Metabolic SyndromeArchives of Internal Medicine, 2006
- The role of cyclic nucleotide phosphodiesterases in the regulation of adipocyte lipolysisJournal of Lipid Research, 2005
- Molecular Regulation of AdipogenesisAnnual Review of Cell and Developmental Biology, 2000
- As Obesity Rates Rise, Experts Struggle to Explain WhyScience, 1998
- Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin ResistanceScience, 1993